RECOMBINANT POLYCLONAL ANTIBODIES: SHOWCASING GRIFOLS' PROPRIETARY PLATFORM AS A CASE STUDY IN GAINING CAPABILITIES VIA EXTERNAL INNOVATION
Tracks
SEVERO OCHOA ROOM
| Tuesday, October 7, 2025 |
| 14:30 - 15:15 |
| SEVERO OCHOA ROOM |
Overview
Sponsor GRIFOLS
Details
This session explores strategies used by the pharmaceutical industry to gain capabilities through external innovation, as well as approaches Biotechs companies use to expand via platform-based growth. Jose Terencio, SVP Discovery at Grifols, and Laia Crespo, Partner at Sanofi Ventures, will share their experience with strategic alignment, investment models, acquisition decisions, integration process and pipeline impact using Grifols' proprietary platform of recombinant polyclonal antibodies as a case study.
Details
Grifols .
Sponsor
Dr Laia Crespo
Partner
Sanofi Ventures
Moderator
Dr Jose Terencio
SVP Discovery
Grifols
Speaker